Purpose: The purpose of this study is to determine the predictive variables for pediatric UC patients who do or do not reach remission within two years of diagnosis
Specific Aims:
This group of pediatric patients will be compared with UC patients who do go into remission within two years of diagnosis in order to find predictors of (non-) remission, correlations, define 'at risk' patients and asses it’s impact on treatment strategy (drugs, strategy and closer follow-up).
Study Period: April 2023-December 2024
Contact: Jonathan Van Hecke